Latest Insider Transactions at Marrone Bio Innovations Inc (MBII)
This section provides a real-time view of insider transactions for Marrone Bio Innovations Inc (MBII). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MARRONE BIO INNOVATIONS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MARRONE BIO INNOVATIONS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 26
2021
|
Kevin Helash Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,795
-32.23%
|
$6,795
$1.47 P/Share
|
|
May 26
2021
|
Timothy B Johnson VP (Field and Technical) |
SELL
Payment of exercise price or tax liability
|
Direct |
5,692
-14.26%
|
$5,692
$1.47 P/Share
|
|
May 26
2021
|
Linda V Moore Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,707
-29.1%
|
$9,707
$1.47 P/Share
|
|
May 26
2021
|
Amit Vasavada SVP & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,704
-16.37%
|
$7,704
$1.47 P/Share
|
|
May 26
2021
|
Keith Pitts SVP & Chief Sust. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,905
-100.0%
|
$23,905
$1.42 P/Share
|
|
May 24
2021
|
Pamela G Marrone Director |
SELL
Open market or private sale
|
Direct |
16,892
-0.74%
|
$16,892
$1.41 P/Share
|
|
May 14
2021
|
Pamela G Marrone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
13,807
+0.6%
|
$13,807
$1.41 P/Share
|
|
Apr 02
2021
|
Kevin Austin Hammill Chief Manufacturing and Supply |
BUY
Grant, award, or other acquisition
|
Direct |
38,942
+33.5%
|
-
|
|
Apr 02
2021
|
Kevin Helash Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,084
+50.0%
|
-
|
|
Apr 02
2021
|
Timothy B Johnson VP (Field and Technical) |
BUY
Grant, award, or other acquisition
|
Direct |
20,514
+33.95%
|
-
|
|
Apr 02
2021
|
Linda V Moore Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,119
+47.45%
|
-
|
|
Apr 02
2021
|
Keith Pitts SVP & Chief Sust. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,905
+50.0%
|
-
|
|
Apr 02
2021
|
Amit Vasavada SVP & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
23,905
+33.69%
|
-
|
|
Mar 15
2021
|
Ospraie Ag Science LLC Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,264,299
+5.96%
|
$0
$0.75 P/Share
|
|
Mar 12
2021
|
Ardsley Advisory Partners LP > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
741,617
+4.25%
|
$0
$0.75 P/Share
|
|
Feb 03
2021
|
Pamela G Marrone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
87,954
+1.29%
|
-
|
|
Jan 29
2021
|
James Boyd President and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+39.27%
|
-
|
|
Jan 15
2021
|
Timothy B Johnson VP (Field and Technical) |
BUY
Exercise of conversion of derivative security
|
Direct |
2,559
+11.65%
|
$2,559
$1.19 P/Share
|
|
Dec 31
2020
|
Ardsley Advisory Partners LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
50,000
+0.31%
|
$50,000
$1.26 P/Share
|
|
Dec 31
2020
|
Ardsley Advisory Partners LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
50,000
-0.31%
|
$50,000
$1.26 P/Share
|
|
Dec 15
2020
|
Ospraie Ag Science LLC Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,476,221
+13.07%
|
$0
$0.75 P/Share
|
|
Dec 14
2020
|
Ardsley Advisory Partners LP > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,648,037
+9.36%
|
$0
$0.75 P/Share
|
|
Dec 08
2020
|
Pamela G Marrone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
31,863
+1.44%
|
$31,863
$1.19 P/Share
|
|
Sep 15
2020
|
Ospraie Ag Science LLC Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,974,213
+3.56%
|
$0
$0.75 P/Share
|
|
Sep 15
2020
|
Ardsley Advisory Partners LP > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
343,341
+2.34%
|
-
|
|
May 01
2020
|
Ardsley Advisory Partners LP > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
429,176
+2.98%
|
-
|
|
Feb 25
2020
|
Ardsley Advisory Partners LP > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
874,314
+6.07%
|
$874,314
$1.0 P/Share
|
|
Dec 19
2019
|
Ardsley Advisory Partners LP > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
874,326
+6.46%
|
$874,326
$1.0 P/Share
|
|
Sep 05
2019
|
Ardsley Advisory Partners LP > 10% Shareholder |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,457,195
+11.01%
|
$1,457,195
$1.0 P/Share
|
|
Aug 07
2018
|
Ardsley Advisory Partners LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
15,000
-0.15%
|
$15,000
$1.96 P/Share
|
|
Aug 06
2018
|
Ardsley Advisory Partners LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,000
-0.1%
|
$20,000
$2.05 P/Share
|
|
Feb 05
2018
|
Ardsley Advisory Partners LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,666,667
+39.18%
|
$0
$0.75 P/Share
|
|
Jul 12
2002
|
Stuart Woolf Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
276,479
-100.0%
|
-
|
|
Jul 12
2002
|
Stuart Woolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
276,479
+50.0%
|
-
|